... treatment effects likely to be engendered by neuroprotective agents or even delayed thrombolysis. A reanalysis of the NINDS rt-PA trial results by Saver [ 55 ] employing a novel assessment of treatment effect was performed. In this reanalysis, the effect of rt-PA treatment on the full range of mRS outcomes...

... to demonstrate the success of thrombolysis. The perfusion weighted/diffusion weighted mismatch, accompanied by large artery occlusion, provides a viable clinical image, which can show the effectiveness of thrombolysis on a case-by-case basis. The perfusion/diffusion mismatch can be recovered if either...

... should be addressed (email [email protected] ). 15 6 2006 © 2006 The Biochemical Society 2006 albumin focal cerebral ischaemia neuroprotection randomized clinical trial stroke thrombolysis Stroke is the third leading cause of death in North America...